CG
KYNB

Cutler Group’s Kyntra Bio KYNB Stock Holding History

Cutler Group’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,572
Closed -$65K – 3945
2023
Q2 		$65K Buy
1,572
+1,548
+6,450% +$640K 0.01% 1153
2023
Q1 		$6K Hold
24
– – ﹤0.01% 2621
2022
Q4 		$7K Hold
24
– – ﹤0.01% 2933
2022
Q3 		$8K Hold
24
– – ﹤0.01% 3270
2022
Q2 		$9K Hold
24
– – ﹤0.01% 3265
2022
Q1 		$9K Sell
24
-40
-63% -$13.9K ﹤0.01% 3690
2021
Q4 		$26K Sell
64
-96
-60% -$29.9K ﹤0.01% 2912
2021
Q3 		$34K Buy
160
+120
+300% +$42.5K ﹤0.01% 2851
2021
Q2 		$3K Buy
+40
New +$23K ﹤0.01% 4757
2020
Q4 		– Sell
-20
Closed -$1K – 5009
2020
Q3 		$1K Hold
20
– – ﹤0.01% 4316
2020
Q2 		$1K Sell
20
-112
-85% -$104K ﹤0.01% 4025
2020
Q1 		$21K Sell
132
-412
-76% -$410K ﹤0.01% 2268
2019
Q4 		$40K Buy
544
+476
+700% +$486K ﹤0.01% 1774
2019
Q3 		$7K Buy
68
+8
+13% +$8.79K ﹤0.01% 2824
2019
Q2 		$3K Sell
60
-200
-77% -$219K ﹤0.01% 3357
2019
Q1 		$13K Buy
260
+208
+400% +$282K ﹤0.01% 2323
2018
Q4 		$15K Buy
+52
New +$58.4K ﹤0.01% 2300
2018
Q1 		– Sell
-716
Closed -$14K – 4671
2017
Q4 		$14K Sell
716
-1,740
-71% -$2.18M ﹤0.01% 2856
2017
Q3 		$83K Sell
2,456
-944
-28% -$995K ﹤0.01% 1813
2017
Q2 		$200K Buy
3,400
+620
+22% +$432K 0.01% 1280
2017
Q1 		$455K Buy
2,780
+2,688
+2,922% +$1.64M 0.02% 686
2016
Q4 		$6K Sell
92
-760
-89% -$379K ﹤0.01% 4736
2016
Q3 		$112K Sell
852
-980
-53% -$462K 0.01% 1708
2016
Q2 		$403K Buy
1,832
+972
+113% +$445K 0.02% 698
2016
Q1 		$261K Buy
860
+480
+126% +$239K 0.02% 857
2015
Q4 		$48K Buy
+380
New +$252K ﹤0.01% 2502

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Cutler Group's KYNB Position: Q1 2024 in Review

Cutler Group reduced its Kyntra Bio (KYNB) stake by 74% in Q1 2024, selling an estimated $4.31K and leaving 36 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #1834.

Cutler Group first reported a position in KYNB in Q1 2016 and has held it in 28 quarters since. The position peaked at $1.05M in Q3 2017. 112 funds tracked by Wall St. Rank hold KYNB as of Q1 2024.

  • Cutler Group held 36 shares of Kyntra Bio worth $2K as of Q1 2024.
  • Cutler Group sold 100 Kyntra Bio shares in Q1 2024, an estimated $4.31K.
  • Kyntra Bio made up ﹤0.01% of Cutler Group's portfolio in Q1 2024, its #1834 holding.
  • Cutler Group first reported a position in Kyntra Bio in Q1 2016 and has held it in 28 quarters since.
  • Cutler Group's Kyntra Bio position peaked at $1.05M in Q3 2017.
  • 112 funds tracked by Wall St. Rank held Kyntra Bio as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.